Yuling Luo
Tracked across 3 events · 19 articles · First seen Jun 02, 2026 · Last active Jul 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: As the founder, CEO, and chair of Alamar Biosciences, Yuling Luo announced the launch of the NULISA DBS Extraction Kit, highlighting the company's commitment to making proteomics more accessible.
Jun 02, 2026 · 7 articles
Tech
Impact: As CEO and founder, Yuling Luo announced the launch and highlighted the panel's potential to accelerate biomarker discovery and early disease detection.
Jul 28, 2026 · 6 articles
Tech
Impact: CEO of Alamar Biosciences, announced the partnership.
Jul 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Yuling Luo live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard